X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
adult (6) 6
female (6) 6
humans (6) 6
index medicus (6) 6
male (6) 6
middle aged (6) 6
aged (5) 5
carcinoma, non-small-cell lung - drug therapy (5) 5
lung cancer, non-small cell (5) 5
oncology (5) 5
carcinoma, non-small-cell lung - pathology (4) 4
care and treatment (4) 4
chemotherapy (4) 4
disease-free survival (4) 4
hematology, oncology and palliative medicine (4) 4
lung cancer (4) 4
analysis (3) 3
carcinoma, non-small-cell lung - genetics (3) 3
clinical trials (3) 3
inhibitor (3) 3
kaplan-meier estimate (3) 3
lung neoplasms - drug therapy (3) 3
medical colleges (3) 3
mutation (3) 3
protein kinase inhibitors - adverse effects (3) 3
tyrosine (3) 3
abridged index medicus (2) 2
acquired-resistance (2) 2
adenocarcinoma (2) 2
aged, 80 and over (2) 2
antineoplastic agents - therapeutic use (2) 2
cancer therapies (2) 2
carcinoma, non-small-cell lung - mortality (2) 2
docetaxel (2) 2
erlotinib (2) 2
gefitinib (2) 2
genes (2) 2
internal medicine (2) 2
lung neoplasms - mortality (2) 2
lung neoplasms - pathology (2) 2
medicine, general & internal (2) 2
molecular targeted therapy (2) 2
nsclc (2) 2
pharmaceutical industry (2) 2
product development (2) 2
protein kinase inhibitors - administration & dosage (2) 2
resistance (2) 2
therapy (2) 2
treatment outcome (2) 2
tumors (2) 2
tyrosine kinase inhibitors (2) 2
3-d microbatteries (1) 1
3-d microlbatteries (1) 1
adolescent (1) 1
adult patients pts (1) 1
afatinib (1) 1
algorithms (1) 1
anaplastic lymphoma (1) 1
angiogenesis (1) 1
anode material (1) 1
anti-pd-l1 antibody (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
antibodies, monoclonal, humanized - adverse effects (1) 1
antibodies, monoclonal, humanized - therapeutic use (1) 1
antimitotic agents (1) 1
antimony (1) 1
antineoplastic agents (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - adverse effects (1) 1
article (1) 1
b7-h1 antigen - analysis (1) 1
bio-bibliography (1) 1
biomarkers (1) 1
biopsy (1) 1
blockade (1) 1
blood-brain barrier (1) 1
blood-brain barrier - drug effects (1) 1
brain metastases (1) 1
c-met (1) 1
cancer (1) 1
carbon nanofibers (1) 1
carcinoma, non-small-cell lung - chemistry (1) 1
carcinoma, non-small-cell lung - enzymology (1) 1
cardiotoxicity (1) 1
cell survival (1) 1
ceramics, glass, composites, natural methods (1) 1
characterization and evaluation of materials (1) 1
chemistry, physical (1) 1
clinical benefit (1) 1
clinical medicine (1) 1
clinical-features (1) 1
complications and side effects (1) 1
criteria (1) 1
crizotinib (1) 1
cross-over studies (1) 1
crystallography (1) 1
csf concentration (1) 1
cyclin-dependent kinases (1) 1
data collection (1) 1
disease (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 5, pp. 577 - 589
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 10, pp. 1011 - 1019
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10027, pp. 1540 - 1550
Summary Background Despite recent advances in the treatment of advanced non-small-cell lung cancer, there remains a need for effective treatments for... 
Internal Medicine | CRITERIA | MEDICINE, GENERAL & INTERNAL | ANTI-PD-L1 ANTIBODY | THERAPY | NSCLC | IMMUNOTHERAPY | PD-L1 | BLOCKADE | NIVOLUMAB | CHEMOTHERAPY | Lung Neoplasms - drug therapy | Carcinoma, Non-Small-Cell Lung - chemistry | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Molecular Targeted Therapy | Patient Selection | Taxoids - therapeutic use | Antibodies, Monoclonal, Humanized - administration & dosage | Antineoplastic Agents - adverse effects | Adult | Female | Taxoids - adverse effects | Carcinoma, Non-Small-Cell Lung - pathology | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Lung Neoplasms - chemistry | Docetaxel | Kaplan-Meier Estimate | Treatment Outcome | Disease-Free Survival | Taxoids - administration & dosage | Aged | B7-H1 Antigen - analysis | Carcinoma, Non-Small-Cell Lung - drug therapy | Antimitotic agents | Medical colleges | Lung cancer, Non-small cell | Antineoplastic agents | Analysis | Chemotherapy | Biopsy | Genes | Lung cancer | Clinical trials | Oncology | Mutation | Tumors | Slopes | Cell survival | Medical treatment | Medical services | FDA approval | Survival | Patients | Medical centres | Pembrolizumab | Randomization | Interactive systems | Immunotherapy | Risk assessment | PD-L1 protein | Biomarkers
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9829, pp. 1879 - 1886
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 4, pp. 452 - 463
Journal Article
Journal Article
Nano Energy, ISSN 2211-2855, 07/2015, Volume 15, pp. 479 - 489
Journal Article
GeoInformatica, ISSN 1384-6175, 07/2016, Volume 20, Issue 3, p. 471
Journal Article
2004, ISBN 8971055154, 701
Book
Journal of Electroceramics, ISSN 1385-3449, 4/2013, Volume 30, Issue 1, pp. 1 - 1
Journal Article
01/2015, ISBN 9781339408200
Graphene plays important roles in technological developments regarding electronic device, environment and energy management and the motivation to prepare... 
Materials science | Nanotechnology
Dissertation
01/2000, ISBN 0612642305
Aluminum-magnesium alloys, used in sheet form, provide substantial strengthening with good ductility as a result of cold work, in addition to excellent... 
Metallurgy | Mechanical engineering
Dissertation
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.